| Literature DB >> 33351785 |
Rachel L Rutishauser1, Christian Deo T Deguit1,2, Joseph Hiatt3,4,5, Franziska Blaeschke3,6,7, Theodore L Roth3,4,5, Lynn Wang1, Kyle A Raymond8,9, Carly E Starke10, Joseph C Mudd10, Wenxuan Chen1, Carolyn Smullin1, Rodrigo Matus-Nicodemos11, Rebecca Hoh1, Melissa Krone12, Frederick M Hecht1, Christopher D Pilcher1, Jeffrey N Martin12, Richard A Koup13, Daniel C Douek11, Jason M Brenchley10, Rafick-Pierre Sékaly14, Satish K Pillai8,9, Alexander Marson1,3,6,7,15,16,17, Steven G Deeks1, Joseph M McCune1, Peter W Hunt1.
Abstract
Although many HIV cure strategies seek to expand HIV-specific CD8+ T cells to control the virus, all are likely to fail if cellular exhaustion is not prevented. A loss in stem-like memory properties (i.e., the ability to proliferate and generate secondary effector cells) is a key feature of exhaustion; little is known, however, about how these properties are regulated in human virus-specific CD8+ T cells. We found that virus-specific CD8+ T cells from humans and nonhuman primates naturally controlling HIV/SIV infection express more of the transcription factor TCF-1 than noncontrollers. HIV-specific CD8+ T cell TCF-1 expression correlated with memory marker expression and expansion capacity and declined with antigenic stimulation. CRISPR-Cas9 editing of TCF-1 in human primary T cells demonstrated a direct role in regulating expansion capacity. Collectively, these data suggest that TCF-1 contributes to the regulation of the stem-like memory property of secondary expansion capacity of HIV-specific CD8+ T cells, and they provide a rationale for exploring the enhancement of this pathway in T cell-based therapeutic strategies for HIV.Entities:
Keywords: AIDS/HIV; Adaptive immunity; Immunology; T cells
Mesh:
Substances:
Year: 2021 PMID: 33351785 PMCID: PMC7934879 DOI: 10.1172/jci.insight.136648
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708